Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
Ajouter des filtres








Gamme d'année
1.
Indian J Ophthalmol ; 2023 Jul; 71(7): 2927
Article | IMSEAR | ID: sea-225162

Résumé

Background: Plaque brachytherapy is an evolving, yet effective globe and vision-sparing modality for the treatment of intraocular tumors by transscleral irradiation of the tumor base with a radioactive implant. The American Brachytherapy Society (ABS) along with the collaboration of the international multicenter Ophthalmic Oncology Task Force (OOTF) was assembled to reach a consensus regarding establishing practice guidelines and setting standards of care for intraocular tumors. The advent of plaque brachytherapy has revolutionized the outcomes of intraocular tumors, thus ensuring globe salvage, reducing morbidity and mortality, and avoiding cosmetic disfigurement. A well-planned dosimetry for plaque brachytherapy results in achieving local tumor control and excellent prognosis. Purpose: This technique provides the advantage of focal radiation, thus eliminating the damage to the adjacent structures, minimal periorbital tissue damage, absence of cosmetic disfigurement owing to lack of retarded bone growth as seen in external beam radiotherapy. Thus, it reduces the risk of metastasis, and with the recent advances, it provides a shorter duration of treatment. Synopsis: In this video, we shall display the concept of plaque brachytherapy, the various types of plaques available, different radiations sources, planning dosimetry and calculations, target disease spectrum, surgical placement, and post-radiation outcomes in terms of local tumor control and prognosis. Highlights: This video highlights the history, basic principles and techniques of plaque brachytherapy and provides an understanding of its applications in the world of ocular oncology.

2.
Indian J Chest Dis Allied Sci ; 2006 Jan-Mar; 48(1): 67-9
Article Dans Anglais | IMSEAR | ID: sea-29734

Résumé

Strongyloides stercoralis is a nematode endemic in tropical and subtropical regions. In immunocompetent subjects, pulmonary disease caused by the parasite is unremarkable but the same can be life threatening in immunocompromised subjects. Though described in literature it is rarely seen in Indian subjects. We report a patient with ARDS due to Strongyloides stercoralis complicating non-Hodgkin's lymphoma with neutropenia.


Sujets)
Sujet âgé , Albendazole/usage thérapeutique , Animaux , Protocoles de polychimiothérapie antinéoplasique/effets indésirables , Antiparasitaires/usage thérapeutique , Cyclophosphamide/effets indésirables , Doxorubicine/effets indésirables , Issue fatale , Humains , Ivermectine/usage thérapeutique , Lymphome malin non hodgkinien/complications , Mâle , Défaillance multiviscérale/étiologie , Neutropénie/étiologie , Prednisolone/effets indésirables , /étiologie , Strongyloides stercoralis/isolement et purification , Strongyloïdose/complications , Vincristine/effets indésirables
SÉLECTION CITATIONS
Détails de la recherche